Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance
- 1 March 2017
- journal article
- research article
- Published by Elsevier BV in Journal of Diabetes and its Complications
- Vol. 31 (3), 537-543
- https://doi.org/10.1016/j.jdiacomp.2016.11.002
Abstract
No abstract availableKeywords
Funding Information
- Medical University, Sofia, Bulgaria (419/2016)
This publication has 68 references indexed in Scilit:
- Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic StatusDiabetes Care, 2016
- Heart Rate–Corrected QT Interval Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Diabetes Heart StudyDiabetes Care, 2014
- Older Subjects With Diabetes and Prediabetes Are Frequently Unaware of Having Distal Sensorimotor PolyneuropathyDiabetes Care, 2013
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008
- High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndromeMetabolism, 2006
- Is Peripheral Neuropathy Associated With Retinopathy and Albuminuria in Individuals With Impaired Glucose Metabolism?Diabetes Care, 2006
- Lower heart rate variability is associated with higher serum high-sensitivity C-reactive protein concentration in healthy individuals aged 46 years or moreInternational Journal of Cardiology, 2006
- Diabetic NeuropathiesDiabetes Care, 2005
- Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndromeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002